Syncope in hypertrophic cardiomyopathy: multivariate analysis of prognostic determinants

Department of Cardiology, University Hospital Eppendorf, Hamburg, Federal Republic of Germany.

Twenty-nine consecutive patients with symptomatic hypertrophic cardiomyopathy and a mean age of 44.8 +/- 12.2 years (range 21 to 63) underwent complex invasive and noninvasive testing to identify a risk profile for syncope. Clinical, morphologic, electrophysiologic and hemodynamic variables at rest and at a symptom-limited pacing rate were analyzed for a significant association with syncope. Exact stepwise logistic regression analysis identified three variables as significant independent predictors of syncope in hypertrophic cardiomyopathy: 1) age less than 30 years (beta = 4.803; p = 0.0007); 2) left ventricular end-diastolic volume index less than 60 ml/m2 (beta = 3.302; p = 0.006); and 3) nonsustained ventricular tachycardia on 72 h ambulatory electrocardiographic monitoring (beta = 2.5909; p = 0.03). The combined occurrence of all three variables had a sensitivity and specificity of 100% in identifying eight patients with syncopal events. Thus, the risk for syncope in hypertrophic cardiomyopathy is high in young patients with the combination of low left ventricular filling volume and episodes of nonsustained ventricular tachycardia. This finding might also explain the mechanism of syncope in hypertrophic cardiomyopathy as low input-low output failure induced by a sudden increase in heart rate in the presence of a low filling volume.

This article has been cited by other articles:

				M. Chowdhary, E. W. K. Peng, and P. K. Sarkar The risk of fatal re-expansion pulmonary oedema in poor left ventricular reserve Interact CardioVasc Thorac Surg, August 1, 2009; 9(2): 350 - 351. [Abstract] [Full Text] [PDF]

				P. Spirito, C. Autore, C. Rapezzi, P. Bernabo, R. Badagliacca, M. S. Maron, S. Bongioanni, F. Coccolo, N.A. M. Estes, C. S. Barilla, et al. Syncope and Risk of Sudden Death in Hypertrophic Cardiomyopathy Circulation, April 7, 2009; 119(13): 1703 - 1710. [Abstract] [Full Text] [PDF]

				L. Williams and M. Frenneaux Syncope in hypertrophic cardiomyopathy: mechanisms and consequences for treatment Europace, September 1, 2007; 9(9): 817 - 822. [Abstract] [Full Text] [PDF]

				Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346. [Full Text] [PDF]

				Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 746 - 837. [Full Text] [PDF]

				P P Dimitrow and J S Dubiel Echocardiographic risk factors predisposing to sudden cardiac death in hypertrophic cardiomyopathy Heart, January 1, 2005; 91(1): 93 - 94. [Full Text] [PDF]

				Guidelines on Management (diagnosis and treatment) of syncope - update 2004: The Task Force on Syncope, European Society of Cardiology Europace, January 1, 2004; 6(6): 467 - 537. [Full Text] [PDF]

				A. J. Marian On predictors of sudden cardiac death in hypertrophic cardiomyopathy J. Am. Coll. Cardiol., March 19, 2003; 41(6): 994 - 996. [Full Text] [PDF]

				R. Roberts and U. Sigwart New Concepts in Hypertrophic Cardiomyopathies, Part I Circulation, October 23, 2001; 104(17): 2113 - 2116. [Full Text] [PDF]

				Task Force on Syncope, European Society of Cardiol, M Brignole, P Alboni, D Benditt, L Bergfeldt, J.J Blanc, P.E Bloch Thomsen, J.G van Dijk, A Fitzpatrick, S Hohnloser, et al. Guidelines on management (diagnosis and treatment) of syncope Eur. Heart J., August 1, 2001; 22(15): 1256 - 1306. [Abstract] [PDF]

				W Arthur and G C Kaye The pathophysiology of common causes of syncope Postgrad. Med. J., December 1, 2000; 76(902): 750 - 753. [Full Text]

				A. T. Yetman, R. M. Hamilton, L. N. Benson, and B. W. McCrindle Long-term outcome and prognostic determinants in children with hypertrophic cardiomyopathy J. Am. Coll. Cardiol., December 1, 1998; 32(7): 1943 - 1950. [Abstract] [Full Text] [PDF]

				L. Lankford and T. Sills Echocardiographic Management of Patients With Hypertrophic Obstructive Ca rdiomyopathy Treated With Dual Chamber Pacemakers Journal of Diagnostic Medical Sonography, September 1, 1995; 11(5): 252 - 255. [Abstract] [PDF]

				A. E. Raizner and K. A. Heck 37-Year-Old Woman With Progressive Fatigue, Syncope, and Chest Pain Circulation, January 1, 1995; 91(1): 231 - 235. [Full Text]